Efficacy of Systane Ultra in Post Menopausal Women With Dry Eye

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01105910

Enrollment

Registered

2010-04-19

Start date

2010-02-28

Completion date

Unknown

Last updated

2016-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Menopausal Dry Eye Subjects

Keywords

Dry Eye, Post Menopausal dry eye

Brief summary

To evaluate the efficacy of Systane Ultra in post menopausal women with dry eye.

Interventions

OTHERSystane Ultra Lubricant Eye Drops

1 to 2 drops in each eye 4 times per day for 30 days

OTHERSensitive Eyes Eye Drops (Bausch & Lomb)

1 to 2 drops in each eye 4 times per day for 30 days

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Post-menopausal (menses ceased more than 12 months prior to the start of the study). 2. Diagnosed for dry eye

Exclusion criteria

1. History of Sjögren's Syndrome or evidence of chronic dry eye syndrome. Confirmed autoimmune connective tissue diseases such as rheumatoid arthritis, fibromyalgia or scleroderma. 2. Active and severe blepharitis, rosacea and associated ocular sequelae. 3. Has any significant eyelid abnormality affecting lid function.

Design outcomes

Primary

Measure	Time frame
Reduction in corneal staining	30 days

Secondary

Measure	Time frame
Patient acceptability / comfort	30 days

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026